http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6040169-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b0c198757da18cf77dfbdcef00abb70
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16634
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5254
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-04
filingDate 1996-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2000-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76ae6c63310820ad2e5be0ec8732cac7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c585ddc0f929fabcd12c72d282655a21
publicationDate 2000-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6040169-A
titleOfInvention Herpes simplex virus-1 deletion variants and vaccines thereof
abstract Novel Herpes simplex viruses and vaccines based on such novel HSV-1 strains are described. In particular, viruses having a deletion in the terminal portion of RL are provided. The virus can be further modified to express heterologous antigens and also engineered to overproduce HSV Light particles. This is achieved by incorporating a ts mutation into the UL26 gene.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11473063-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114375331-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10947513-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10570377-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10612005-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10626377-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11427810-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022117073-A1
priorityDate 1991-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0175261-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0243155-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5328688-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4859587-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24180930

Total number of triples: 38.